Medicare Enrolled

Dr. Patricia Eshaghian, M.D.

Pulmonary Disease · Los Angeles, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Consulting-driven
UCLA DIVISION OF PULMONARY AND CRITICAL CARE, Los Angeles, CA 90095
3108255615
In practice since 2008 (17 years)
NPI: 1114191186 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Eshaghian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Eshaghian? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Eshaghian

Dr. Patricia Eshaghian is a pulmonary disease specialist in Los Angeles, CA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Eshaghian performed 648 Medicare services across 337 unique beneficiaries.

Between the years covered by Open Payments, Dr. Eshaghian received a total of $9,937 from 12 pharmaceutical and/or device companies across 35 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Eshaghian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ 648 Medicare services $9,937 industry payments

Medicare Practice Summary

Medicare Utilization ↗
648
Medicare services
Bottom 49% in CA for pulmonary disease
337
Unique beneficiaries
$111
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~38 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
145 $188 $1,800
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
132 $78 $508
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
105 $102 $680
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
91 $109 $858
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
75 $67 $470
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
39 $155 $960
Expiratory airflow and volume test
A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume.
18 $23 $181
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
17 $48 $354
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
14 $34 $131
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
12 $72 $297
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,937
Total received (2018-2024)
Avg $1,656/year across 6 years
Top 16% in CA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
12
Companies
35
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$8,202 (82.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,709 (17.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$26 (0.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$288
2023
$346
2022
$147
2020
$4,018
2019
$4,928
2018
$210

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Pharming Healthcare, Inc.
$121
Insmed, Inc.
$91
Shionogi Inc
$76
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$8,202
Gilead Sciences, Inc.
$468
Insmed, Inc.
$335
Breathe Technologies, Inc.
$225
Inspire Medical Systems, Inc.
$200
Mylan Specialty L.P.
$134
Alcresta Therapeutics, Inc.
$129
Pharming Healthcare, Inc.
$121
Shionogi Inc
$76
Allergan Inc.
$19
Electromed, Inc.
$18
Paratek Pharmaceuticals, Inc.
$12
Top 3 companies account for 90.6% of all-time payments
Associated products mentioned in payments ›
Arikayce · Cayston · Fetroja · INSPIRE · JOENJA · Life2000 Ventilation System · NUZYRA · RELIZORB · SMARTVEST · Tobi Podhaler · Veklury · Yupelri · ZENPEP
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (82%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.

Looking for a pulmonary disease specialist in Los Angeles?
Compare pulmonary diseases in the Los Angeles area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
250
Per 100K population
2.5
County median income
$87,760
Nearest hospital
RONALD REAGAN UCLA MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Eshaghian is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 16% of CA peers, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Eshaghian experienced with critical care, first 30-74 min?
Based on Medicare claims data, Dr. Eshaghian performed 145 critical care, first 30-74 min services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Eshaghian receive payments from pharmaceutical companies?
Yes. Dr. Eshaghian received a total of $9,937 from 12 companies across 35 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Eshaghian's costs compare to other pulmonary diseases in Los Angeles?
Dr. Eshaghian's average Medicare payment per service is $111. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Eshaghian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →